1-7 of 7
Eline Luning Prak
Close
Sort by
Journal Articles

Adoptive Immune Responses to Sars-Cov2 Vaccination in CART19 Treated Patients

Kalpana Parvathaneni, Kyabeth Toress-Rodriguez, Wenzhao Meng, James Knox, Xiaoming Xu, Daniela Weiskopf, Noelle V Frey, Eline Luning-Prak, Alfred L Garfall, Michael Betts, Wei-Ting Hwang, David L Porter, Carl H June, Ali Naji, Vijay Bhoj
Journal: Blood
Blood (2021) 138 (Supplement 1): 1757.
https://doi.org/10.1182/blood-2021-153730
Published: 2021
Journal Articles

KI Intolerance Study: A Phase 2 Study to Assess the Safety and Efficacy of Umbralisib (TGR-1202) in Patients with Chronic Lymphocytic Leukemia (CLL) Who Are Intolerant to Prior BTK or PI3K-δ Inhibitor Therapy

Anthony R. Mato, MD, Bruce D. Cheson, MD, Nicole Lamanna, MD, John M. Pagel, MD PhD, Frederick Lansigan, MD, Paul M. Barr, MD, Jeffrey J. Pu, MD PhD, Colleen Dorsey, BSN, RN, Elizabeth T Chatburn, BS, Jakub Svoboda, MD, Stephen J. Schuster, MD, Eline Luning-Prak, MD PhD, Patricia Tsao, MD PhD, Andrea Sitlinger, MD, Chaitra S. Ujjani, MD, Dana Paskalis, Peter Sportelli, BS, Hari P Miskin, MSc, Michael S. Weiss, Danielle M. Brander, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4314.
https://doi.org/10.1182/blood.V130.Suppl_1.4314.4314
Published: 2017
Journal Articles

Phase I/II Study of Pembrolizumab in Combination with Ublituximab (TG-1101) and Umbralisib (TGR-1202) in Patients with Relapsed/Refractory CLL

Anthony R. Mato, MD, Colleen Dorsey, BSN, RN, Elizabeth T Chatburn, BS, Jessica Geoghegan, Stephen J. Schuster, MD, Jakub Svoboda, MD, Pamela S. Becker, MD PhD, Elise A. Chong, MD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Kaitlin Kennard, RN, BSN, Eline Luning-Prak, MD PhD, Patricia Tsao, MD PhD, Mitchell E. Hughes, PharmD, BCPS, BCOP, Michelle Purdom, PhDRN, Dana Paskalis, Peter Sportelli, BS, Hari P Miskin, MSc, Michael S. Weiss, Mazyar Shadman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3010.
https://doi.org/10.1182/blood.V130.Suppl_1.3010.3010
Published: 2017
Journal Articles

Mechanisms of B Cell Tolerance after in Utero Hematopoietic Cell Transplantation

Lauren Elizabeth McClain, MD, Grace Lee, Aimee G Kim, MD, Patricia Tsao, Eline Luning Prak, MD PhD, Alan W Flake, MD, William H Peranteau, MD
Journal: Blood
Blood (2015) 126 (23): 4289.
https://doi.org/10.1182/blood.V126.23.4289.4289
Published: 2015
Journal Articles

Detection of the Malignant B Cell Clone in Multiple Myeloma Via High Throughput Sequencing Is Robust to Significant Levels of Somatic Hypermutation

Christopher S Carlson, PhD, Alfred L. Garfall, MD, Wenzhao Meng, PhD, Robert Daber, PhD, Bochao Zhang, Uri Hershberg, PhD, Adam D. Cohen, MD, Dan T. Vogl, Weiss Brendan, Martin Carroll, MD, Edward A. Stadtmauer, Eline Luning Prak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3413.
https://doi.org/10.1182/blood.V124.21.3413.3413
Published: 2014
Journal Articles

All Clones Are Not Equal: Somatic Hypermutation Significantly Enhances The Utility Of Tumor Tagging Rearrangements At IG Light Chain Loci In B Cell Malignancy

Christopher S Carlson, PhD, Bryan Howie, PhD, Alfred L. Garfall, MD, Eline Luning Prak, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1376.
https://doi.org/10.1182/blood.V122.21.1376.1376
Published: 2013
Journal Articles

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Clinical Trials & Observations
Edward A. Stadtmauer, Dan T. Vogl, Eline Luning Prak, Jean Boyer, Nicole A. Aqui, Aaron P. Rapoport, Kenyetta R. McDonald, Xiaoling Hou, Heather Murphy, Rita Bhagat, Patricia A. Mangan, Anne Chew, Elizabeth A. Veloso, Bruce L. Levine, Robert H. Vonderheide, Abbas F. Jawad, Carl H. June, Kathleen E. Sullivan
Journal: Blood
Blood (2011) 117 (1): 63–71.
https://doi.org/10.1182/blood-2010-07-296822
Published: 2011